000258582 001__ 258582
000258582 005__ 20240308115302.0
000258582 0247_ $$2URN$$aurn:nbn:de:hbz:5-71080
000258582 037__ $$aDZNE-2023-00611
000258582 1001_ $$0P:(DE-2719)2811777$$aOffermann, Nina$$b0$$udzne
000258582 245__ $$aRole of the proton channel HVCN1 in the regulation of neutrophil activation
000258582 260__ $$c2023
000258582 300__ $$a126
000258582 3367_ $$2DataCite$$aOutput Types/Dissertation
000258582 3367_ $$2ORCID$$aDISSERTATION
000258582 3367_ $$2BibTeX$$aPHDTHESIS
000258582 3367_ $$02$$2EndNote$$aThesis
000258582 3367_ $$0PUB:(DE-HGF)11$$2PUB:(DE-HGF)$$aDissertation / PhD Thesis$$bphd$$mphd$$s1689148442_3268
000258582 3367_ $$2DRIVER$$adoctoralThesis
000258582 502__ $$aDissertation, Rheinische Friedrich-Wilhelms-Universität Bonn, 2023$$bDissertation$$cRheinische Friedrich-Wilhelms-Universität Bonn$$d2023$$o2023-05-25
000258582 520__ $$aExcessive neutrophil activation is a feature of many inflammatory diseases. Neutrophils from affected patients are prone to release reactive oxygen species (ROS) and toxic granule proteins or to undergo NETosis, a special form of cell death characterized by the release of extracellular DNA traps (NETs). Indeed, neutrophils have been shown to play a critical role in the development of autoimmune diseases, as NETs provide autoantigens, such as double-stranded DNA in systemic lupus erythematosus (SLE) or myeloperoxidase (MPO) in ANCA-associated vasculitis. Nonetheless, the molecular switches regulating neutrophil effector functions remain to be further characterized.HVCN1 is the only voltage-gated proton channel in mammals that regulates pH and membrane potential during neutrophil activation. Its function supports the electrogenic activity of the ROS-generating enzyme NADPH oxidase. Therefore, NADPH oxidase-dependent ROS production is significantly impaired in the absence of HVCN1. However, not much is known about how HVCN1 regulates neutrophil downstream functions.Therefore, in the first part of my thesis, I further investigated the role of HVCN1 in neutrophils. I demonstrated that PMA-stimulated NETosis and MPO release were significantly increased in HVCN1−/− neutrophils. Fittingly, HVCN1−/− neutrophils showed atypical mobilization of calcium, increased histone citrullination, and high mitochondrial ROS caused by calcium-dependent mitochondrial depolarization. Increased NETosis, MPO release, and mitochondria ROS could be rescued by intracellular calcium chelation but not by antioxidants, suggesting that calcium is the primary determinant of increased NETosis susceptibility in HVCN1−/− neutrophils.I further examined the consequences of HVCN1 deficiency in vivo. In agreement with previous reports, young HVCN1−/− mice did not exhibit a pathogenic phenotype, however we detected a mild (auto-) inflammatory phenotype in aged, female HVCN1−/− mice. Likewise, HVCN1−/− mice showed more severe pathology in two models of inflammation. Correspondingly, we found HVCN1 to be downregulated in neutrophils from SLE patients in two separate datasets. This is the first study to show that HVCN1 deficiency increases the inflammatory capacity of murine neutrophils in vitro and in vivo, suggesting that downregulation of HVCN1 may have implications for human disease.
000258582 536__ $$0G:(DE-HGF)POF4-352$$a352 - Disease Mechanisms (POF4-352)$$cPOF4-352$$fPOF IV$$x0
000258582 8564_ $$uhttps://hdl.handle.net/20.500.11811/10903
000258582 8564_ $$uhttps://pub.dzne.de/record/258582/files/Dissertation%20Nina%20Offermann.pdf$$yPublished on 2023-07-01. Available in OpenAccess from 2024-07-01.
000258582 8564_ $$uhttps://pub.dzne.de/record/258582/files/Dissertation%20Nina%20Offermann.pdf?subformat=pdfa$$xpdfa$$yPublished on 2023-07-01. Available in OpenAccess from 2024-07-01.
000258582 909CO $$ooai:pub.dzne.de:258582$$popenaire$$popen_access$$purn$$pdriver$$pVDB$$pdnbdelivery
000258582 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2811777$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b0$$kDZNE
000258582 9131_ $$0G:(DE-HGF)POF4-352$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vDisease Mechanisms$$x0
000258582 9141_ $$y2023
000258582 915__ $$0StatID:(DE-HGF)0530$$2StatID$$aEmbargoed OpenAccess
000258582 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
000258582 920__ $$lyes
000258582 9201_ $$0I:(DE-2719)1013033$$kAG Capasso$$lImmune Regulation$$x0
000258582 9201_ $$0I:(DE-2719)1040260$$kLibrary and Information Services$$lLibrary and Information Services$$x1
000258582 980__ $$aphd
000258582 980__ $$aVDB
000258582 980__ $$aUNRESTRICTED
000258582 980__ $$aI:(DE-2719)1013033
000258582 980__ $$aI:(DE-2719)1040260
000258582 9801_ $$aFullTexts